Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats

被引:34
作者
Hefco, V
Yamada, K
Hefco, A
Hritcu, L
Tiron, A
Olariu, A
Nabeshima, T
机构
[1] Al I Cuza Univ, Dept Physiol, Iasi 6600, Romania
[2] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan
关键词
chlorisondamine; nicotine; scopolamine; sulpiride; memory;
D O I
10.1016/S0014-2999(03)02034-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Scopolamine dose-dependently inhibits passive avoidance latency and decreases spontaneous alternation in the Y-maze, suggesting effects on long-term and short-term memory, respectively. Chlorisondamine (10 mg/kg), a compound which produces a long-lasting central nicotinic receptor blockade, did not affect short-term and long-term memory performance. In normal rats, nicotine at the doses of 0.3, 1.0, and 3.0 mg/ kg administered once had a facilitating effect on short-term memory; a higher dose (3.0 mg/kg) did not show a more pronounced effect than a lower one (0.3 mg/kg). Nicotine, by activating the nicotinic acetylcholine receptors, attenuated the impairment of short-term memory induced by muscarinic or dopamine D2 receptor blockade. On long-term memory, a single dose of nicotine (0.3, 1.0, 3.0 mg/kg) did not affect memory performance, but improved it after chronic (10 consecutive days, 0.3 mg/kg) administration. The antiamnesic effect of nicotine administered once was observed in scopolamine-, scopolamine + chlorisondamine- or sulpiride-treated rats. These results suggest that the antiamnesic effect of nicotine can result from an action at nicotinic receptors subtypes not blocked by chlorisondamine or at nonnicotinic receptors. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 25 条
[1]   SITES AND MECHANISMS FOR NICOTINES ACTION IN THE BRAIN [J].
ABOOD, LG ;
REYNOLDS, DT ;
BOOTH, H ;
BIDLACK, JM .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1981, 5 (04) :479-486
[2]   CHARACTERIZATION OF THE LOCOMOTOR STIMULANT ACTION OF NICOTINE IN TOLERANT RATS [J].
CLARKE, PBS ;
KUMAR, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 80 (03) :587-594
[3]   EFFECTS OF CHLORISONDAMINE ON NICOTINIC RECEPTOR-BINDING IN WHOLE-BRAIN AND NICOTINE-INDUCED CHANGES IN LOCOMOTOR-ACTIVITY IN RATS [J].
DECKER, MW ;
MAJCHRZAK, MJ ;
CADMAN, ED ;
ARNERIC, SP .
DRUG DEVELOPMENT RESEARCH, 1994, 31 (02) :89-94
[4]   EFFECTS OF SYSTEMIC AND INTRACEREBROVENTRICULAR ADMINISTRATION OF MECAMYLAMINE, A NICOTINIC CHOLINERGIC ANTAGONIST, ON SPATIAL MEMORY IN RATS [J].
DECKER, MW ;
MAJCHRZAK, MJ .
PSYCHOPHARMACOLOGY, 1992, 107 (04) :530-534
[5]   DIVERSITY OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS - LESSONS FROM BEHAVIOR AND IMPLICATIONS FOR CNS THERAPEUTICS [J].
DECKER, MW ;
BRIONI, JD ;
BANNON, AW ;
ARNERIC, SP .
LIFE SCIENCES, 1995, 56 (08) :545-570
[6]   DISSECTION OF MEMORY FORMATION - FROM BEHAVIORAL PHARMACOLOGY TO MOLECULAR-GENETICS [J].
DEZAZZO, J ;
TULLY, T .
TRENDS IN NEUROSCIENCES, 1995, 18 (05) :212-218
[7]   PROACTIVE-INTERFERENCE EFFECTS ON SHORT-TERM-MEMORY IN RATS .1. BASIC PARAMETERS AND DRUG EFFECTS [J].
DUNNETT, SB ;
MARTEL, FL .
BEHAVIORAL NEUROSCIENCE, 1990, 104 (05) :655-665
[8]   THE SEPTOHIPPOCAMPAL PATHWAY - STRUCTURE AND FUNCTION OF A CENTRAL CHOLINERGIC SYSTEM [J].
DUTAR, P ;
BASSANT, MH ;
SENUT, MC ;
LAMOUR, Y .
PHYSIOLOGICAL REVIEWS, 1995, 75 (02) :393-427
[9]   CHARACTERIZATION OF NICOTINIC RECEPTOR-MEDIATED [H-3] DOPAMINE RELEASE FROM SYNAPTOSOMES PREPARED FROM MOUSE STRIATUM [J].
GRADY, S ;
MARKS, MJ ;
WONNACOTT, S ;
COLLINS, AC .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) :848-856
[10]  
HEFCO V, 2000, ANN U IASI, V46, P169